Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in Patients with Wet Age-Related Macular Degeneration

Table 3

Patients of S (+) and S (−) group.

#	Age (years)	Sex	logMAR BCVA	CNV area (mm^2)	Before MDA (pmol/mL)	After MDA (pmol/mL)
S(+) group
1	81	M	0.70	9.09	8.94	7.41
2	81	F	0.70	6.70	8.45	10.23
3	80	M	0.30	1.51	8.45	9.46
4	74	M	0.00	11.41	10.74	9.46
5	74	M	0.10	7.37	9.71	7.68
6	73	F	0.40	1.45	9.52	8.90
7	72	F	0.22	0.85	11.07	9.46
8	69	M	0.30	7.27	14.28	8.86
9	68	F	0.30	1.01	8.94	10.23
10	50	F	0.00	0.30	13.29	6.91
S(−) group
1	94	F	0.30	0.85	9.71	9.98
2	81	F	0.30	6.61	8.69	8.51
3	80	M	0.40	10.69	8.90	9.54
4	78	M	0.10	1.73	9.71	10.41
5	74	M	0.22	5.68	8.32	9.54
6	74	F	0.70	5.53	9.71	10.74
7	67	F	0.10	1.25	10.41	12.17
8	59	F	0.22	8.53	9.71	13.30
9	55	M	0.22	1.12	9.71	10.23
10	54	M	0.22	4.18	10.48	9.72